SupplementsSleepEvidence: preliminary
The short version
- Pure apigenin and chamomile extract are not interchangeable.
- Human sleep trials have tested chamomile preparations, not a measured dose of isolated apigenin.
- There is no clinically established sleep dose, ideal timing or upper intake level for pure apigenin.
- Anyone taking regular medication should check for interactions before using a concentrated flavonoid supplement.
What apigenin is
Apigenin is a flavone found in parsley, celery, chamomile and several other plants. A capsule labelled apigenin is a concentrated isolated compound, not simply dried chamomile in another package.
That distinction matters. Chamomile contains many potentially active compounds, and its apigenin content varies with the plant, extraction method and product. A result from chamomile tea or extract cannot tell us what 25 or 50 mg of purified apigenin will do.
Why it is linked with sleep
Apigenin is often described as acting on GABA-A receptors, part of the brain's inhibitory signalling system. That is a plausible mechanism, but receptor and animal findings do not establish a treatment effect in people. A 2024 review reached the same practical conclusion: the biology is interesting while direct clinical evidence remains sparse.1
What the human studies tested
A 2011 placebo-controlled pilot trial in 34 adults with chronic primary insomnia tested a standardised chamomile extract. It found no statistically significant improvement in the main sleep-diary outcomes, although some daytime measures moved in a favourable direction.2
A 2017 randomised trial in 60 older adults reported better questionnaire-rated sleep quality after chamomile extract.3 That is a useful signal, but it cannot be assigned to apigenin alone: the preparation contained the rest of chamomile's chemistry too.
The honest verdict: chamomile has limited and mixed human evidence; isolated apigenin has a direct human sleep-evidence gap.
Dose: what the label does not tell you
Pure apigenin products commonly provide doses in the tens of milligrams, but a common retail dose is not a clinically validated dose. No reliable human trial has shown that a particular amount improves sleep, that a larger dose works better, or when it should be taken.
Food Health Lab therefore does not present a “therapeutic” dose. If you still choose to try it, favour a single-ingredient product with transparent third-party testing, avoid adding several new sleep supplements at once, and stop if it causes unwanted effects or no meaningful benefit.
Safety and interactions
Short-term safety data for isolated apigenin supplements are limited. Laboratory work suggests concentrated apigenin can affect drug-metabolising enzymes and transport proteins, but the size and clinical importance of those effects in people remain uncertain.4
Use extra caution with sedating medicines, anticoagulant or antiplatelet treatment, and medicines with a narrow therapeutic range. Avoid concentrated apigenin during pregnancy or breastfeeding because adequate safety data are lacking. Chamomile-derived products may also be unsuitable for people allergic to plants in the daisy family.
Bottom line
Apigenin is biologically credible and worth studying, but it is not yet an evidence-based insomnia treatment. The strongest defensible description is a plausible experimental supplement whose direct human sleep evidence has not caught up with its popularity.
References
- Kramer DJ, Johnson AA. Apigenin: a natural molecule at the intersection of sleep and aging. Front Nutr. 2024. PMID 38476603.
- Zick SM, et al. Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: a randomized placebo-controlled pilot study. BMC Complement Altern Med. 2011. PMID 21939549.
- Abdullahzadeh M, et al. Investigation effect of oral chamomilla on sleep quality in elderly people in Isfahan: A randomized control trial. J Educ Health Promot. 2017. PMID 28616420.
- Tang D, et al. Pharmacokinetic properties and drug interactions of apigenin, a natural flavone. Expert Opin Drug Metab Toxicol. 2017. PMID 27766890.
This article summarises adult nutrition research for education. It is not a substitute for individual medical advice; consult a professional before starting a supplement, in pregnancy, or alongside medication.